[ANN] Pharmatech AI ($PCH): 120k m² RWA Med Research Center & AI Model, PRE-SALE

[Pharmatech AI]

Pharmatech AI ($PCH) | World's First AI-Driven Pharma RWA Token | Pre-Sale LIVE

Welcome to the official announcement thread of Pharmatech AI, a groundbreaking project bridging advanced AI, pharmaceutical research, and blockchain technology.

Website: https://pharmatech-ai.com/ | Whitepaper: Read Here

Telegram: t.me/pharmatechAI | X (Twitter): x.com/pharmatechAI

🧬 Welcome to the Future: 120,000 m² RWA Med Research Center in Germany & AI Model

What is Pharmatech AI?

Pharmatech AI is an innovative research company using a proprietary AI model (AI-MDIP) to drastically accelerate and reduce the cost of developing new drug combinations and medications. We focus on high-potential areas: Pain Therapy, Natural Product Research (Cannabinoids), and Nanomedicine.

Our mission is to become a global leader in AI-driven cannabinoid-based therapy development.

Our Advantages (USPs):

• AI Multi-Drug Interaction Predictor (AI-MDIP): A sophisticated AI model using Graph Neural Networks (GNNs) and Transformers to predict molecular interactions with unparalleled precision.
  
• Exclusive Cannabis Data: Our own "MDIP Practical Laboratory Grow" generates over 50,000 proprietary data points per cycle, giving our AI a unique, competitive data edge.
  
• Sustainable Research Center: A 60-hectare campus in Germany powered by a 55 MWp solar farm, ensuring energy self-sufficiency and a positive CO2 footprint.
  
• Focused Research: We are targeting massive markets with specific, high-value applications.

The $PCH Token: Utility & Value Accrual

The $PCH token is the backbone of the Pharmatech AI ecosystem, designed for real utility and value sharing.

• Revenue Sharing: 70% of all platform fees and licensing revenues are distributed quarterly to $PCH stakers in stablecoins.
  
• Advanced Staking: Lock your tokens to earn a share of the revenue with multiplier bonuses for longer commitments.
  
• Buyback & Burn: 10% of all revenue is used to buy back and permanently burn $PCH tokens, creating deflationary pressure.
  
• Governance: Stakers gain voting rights on key project decisions.
  
• Access & Licensing: Token used for payments on our future B2B SaaS platform and data marketplace.

This isn't just a token; it's a share in the success of a real, revenue-generating biotech company.

Recent Milestones & Traction

• $5M Investment: Secured $5 million strategic investment from Rollman Management (source)
  
• QuantifAI Partnership: Strategic alliance with institutional-grade quant-trading platform
  
• Wag3s Partnership: AI-driven accounting and operational infrastructure partnership
  
• Research Expansion: Successful establishment of MDIP Lab Grow facility
  
• Technology Validation: AI-MDIP model achieving unprecedented prediction accuracy
  
• Community Growth: Rapidly expanding global community and investor base

Tokenomics: Transparent and Sustainable

• Token Name: Pharmatech AI ($PCH)
  
• Total Supply: 1,000,000,000 $PCH (Fixed, No Inflation)
  
• Vesting: Transparent vesting schedules for team, advisors, and investors.

A detailed vesting schedule and full tokenomics are available in our whitepaper.

Roadmap & Future Plans

• Q4 2024: $PCH Token Launch and Exchange Listings
  
• Q1 2025: Initial Pharma partnerships and AI-MDIP beta testing
  
• Q2 2025: Launch of AI-MDIP B2B SaaS platform
  
• 2026: First licensing deals with major pharmaceutical companies
  
• 2027: Target: 500+ platform subscribers and $100M+ licensing revenue

⏰ Pre-Sale Details

The pre-sale for the $PCH token is now open. This is your chance to get in early on a project that combines the immense potential of AI, biotech, and crypto.

For detailed instructions, current price, and to participate, visit our official website:

>>> CLICK HERE TO JOIN THE $PCH PRE-SALE <<<

--------------------------------------------------------------------------------------------------------

Team & Advisors: Our team consists of seasoned experts in pharmaceuticals, cannabis cultivation, AI research, and blockchain. Full profiles are on our website.
Incubator: Backed by Synergy Media, a leading Web3 agency in the DACH region.

We are happy to answer your questions below!

Website: https://pharmatech-ai.com/ | Whitepaper: Read Here
Telegram: t.me/pharmatechAI | X (Twitter): x.com/pharmatechAI

[Emerison]

"Hi team,
Just dove into the Pharmatech AI thread and I'm genuinely impressed. What I like most is your AI-MDIP model—using Graph Neural Networks and Transformers for predicting drug interactions sounds like a game-changer for speeding up cannabinoid-based therapies. The fact that it's backed by your own proprietary cannabis data from the MDIP Lab Grow (50k+ data points per cycle!) gives it a real edge over generic AI tools. Plus, the sustainable 60-hectare solar-powered campus in Germany? That's forward-thinking for biotech.
Excited to see the pre-sale progress and upcoming SaaS launch in Q2 2025. Will keep an eye on this—rooting for those $100M+ licensing deals by 2027!
Best,
[My Bitcointalk Username= Emerison]

[Emerison]

Hey Pharmatech AI team,
Great ANN—thanks for sharing the details. After reading through, what stands out most to me is the revenue-sharing model for $PCH stakers (70% of fees in stablecoins) combined with the buyback & burn mechanism. It's a smart way to align token holders with real biotech revenue, especially targeting high-value markets like pain therapy and nanomedicine. The $5M from Rollman Management adds serious credibility, and the QuantifAI partnership for quant-trading integration? That's innovative for a pharma RWA play.

[CryptoCheckCheck]

This is a compelling project. A 70% revenue share for stakers is an exceptionally high number that would normally raise red flags, but it changes the context significantly when you see that the Pharmatech AI team has an established, existing company behind them. This existing structure and the secured $5M investment make the ambitious tokenomics seem more viable and suggest they have the foundation to support it. It's this level of tangible backing that makes me seriously consider an investment, as it feels more substantial than a typical token launch.

[Kosmoslaurenmart]

Wooooow I'm so Excited to see Pharmatech AI combining AI and biotech to revolutionize pharma research! Can't wait to learn more about the AI-MDIP model and its potential impact on the industry. Good luck with the pre-sale and future developments!
Kudos to the team because I believe pharmaceutical AI is on a big dream and it's counting down to reality